Skip to main content
Medical Reference · Condition Monograph

Gallbladder Cancer

담낭암

A cancer that arises in the gallbladder; because there are few early symptoms, it is often detected late. Managing risk factors such as gallstones and early detection through imaging are important.

History

Gallbladder cancer is a cancer that begins in the gallbladder (a small, pouch-shaped organ attached to the underside of the liver). The gallbladder stores the bile produced by the liver and, after meals, sends it to the intestine to help digest fat. In the past, because the gallbladder lies deep inside the body and there are almost no particular symptoms in the early stage, diagnosis was often delayed. For this reason, long ago it was common for the disease to be mistaken for other digestive disorders until it was confirmed by surgery or testing, or to be discovered only after obvious symptoms such as jaundice had appeared.

As imaging tests advanced, the course of diagnosis changed. As abdominal ultrasound (US) became widespread, abnormal findings such as gallstones, gallbladder wall thickening, polyps, and masses could be identified relatively easily, and as contrast-enhanced CT and MRI became common, the extent of the tumor, liver invasion, and lymph node metastasis could be evaluated more accurately. In addition, magnetic resonance cholangiopancreatography (MRCP) helped in understanding the level of bile duct obstruction and the structure of the bile ducts.

In terms of treatment, the principle of varying the extent of surgery according to the stage was established, and pre- and postoperative adjuvant chemotherapy has gradually become part of standard treatment. Recently, options such as targeted therapy and immunotherapy have been discussed according to the characteristics of the tumor, and treatment is developing in the direction of expanding individualized treatment.

Causes

The cause of gallbladder cancer is difficult to state definitively as a single factor; it is understood that the risk of developing it rises as several risk factors overlap. The most well-known risk factors are gallstones and chronic inflammation. When gallstones remain in the gallbladder for a long time, the gallbladder wall is repeatedly irritated and inflammation may persist; in such an environment, cells repeatedly undergo damage and regeneration, increasing the likelihood that abnormal changes will accumulate. However, having gallstones does not mean that everyone will develop gallbladder cancer, and it is appropriate to understand gallstones as "a factor that can increase the risk."

Gallbladder polyps are also an important factor. A gallbladder polyp is a condition in which the gallbladder mucosa protrudes like a lump; most are benign, but when they grow larger or have a suspicious shape, the possibility of cancer or a precancerous lesion is considered. The risk has also been known to be high in cases with pronounced chronic changes, such as a condition in which the gallbladder wall becomes calcified (so-called porcelain gallbladder).

In addition, situations in which bile and pancreatic juice mix abnormally or reflux, as in structural abnormalities of the bile ducts (e.g., pancreaticobiliary maljunction), can irritate the gallbladder mucosa over a long period. In terms of lifestyle, factors such as obesity, smoking, and diabetes may act to raise overall cancer risk. However, rather than definitively attributing a specific cause to an individual, the perspective that several factors can accumulate over a long period is important.

Genetic Epidemiology

Gallbladder cancer is often regarded not as "a disease determined by genetics alone," but as a disease in which genetic predisposition and environmental factors act together. There are reports that the risk may be somewhat higher when a close family member has had gallbladder cancer or biliary tract cancer, but this must be considered together with not only genetic influences but also the influence of factors shared within families, such as a constitution prone to gallstones, dietary habits, living environment, and conditions that cause chronic inflammation.

At the level of cancer cells, various genetic changes can be observed. Normal cells are regulated to grow and divide only when needed, but cancer cells change in ways such that growth signals are excessively switched on, the function of repairing damaged DNA declines, or cells that should originally die survive. In gallbladder cancer as well, these changes appear in various combinations, and the pattern may differ from patient to patient.

The reason this field is clinically important is that, in some patients, the molecular characteristics of the tumor can influence treatment choices. In advanced or recurrent situations, the possibility of applying targeted therapy or immunotherapy is sometimes reviewed through genetic testing or biomarker evaluation. However, rather than being a standard procedure applied equally to all patients, it is often used as an "additional evaluation" to broaden treatment options.

General Epidemiology

Gallbladder cancer is not a very common cancer overall, but differences in incidence between regions and population groups are relatively large. The reason it is reported more commonly in some regions is understood to be the combined effect of factors such as the prevalence of gallstones, chronic cholecystitis, infectious factors, access to healthcare, and diet. Generally, the risk tends to increase with age, and there are also reports that it is more common in women.

Because gallbladder cancer does not have clear early symptoms, its discovery is often delayed. In particular, when the tumor is confined to the inside of the gallbladder, there may be no pain or jaundice, and blood tests may also be normal. Conversely, if jaundice has developed, it may be a situation accompanied by bile duct obstruction, which is often a relatively advanced state.

One clinically important feature is that there are cases in which a cholecystectomy is performed because of gallstones and cancer is incidentally discovered on the postoperative pathological examination. Such cases may be at a relatively early stage, and the direction of further treatment may differ. Therefore, after the gallbladder is removed, the process of checking the pathology results is important regardless of the reason for surgery.

Pathogenesis

Gallbladder cancer is usually explained as a process in which, as irritation and inflammation accumulate over a long period, the normal mucosa gradually undergoes abnormal changes (precancerous changes) and progresses to cancer. When gallstones repeatedly scrape and press on the gallbladder wall, or when bile flow worsens and inflammation persists for a long time, the mucosal cells repeatedly undergo damage and regeneration. The longer this process continues, the greater the likelihood that damage will accumulate in the cells' genetic information (DNA), and when the mechanisms that control cell division break down, abnormal proliferation can begin.

Because the gallbladder is a space where bile pools, irritation from the components of bile itself can also have an effect. When bile stagnates, the mucosa is more easily damaged, and when a bacterial infection accompanies it, the inflammatory response becomes stronger and mucosal changes may accelerate. In structural abnormalities (e.g., pancreaticobiliary maljunction), pancreatic juice can reflux toward the gallbladder, so that irritation of the mucosa may persist.

Ultimately, the explanation most helpful for the general public is to understand gallbladder cancer not as "a disease that suddenly appears one day," but as a cumulative process in which long-term irritation, inflammation, and genetic changes accumulate step by step.

Symptoms

In the early stage, gallbladder cancer often causes almost no symptoms or very vague ones. For this reason, it can begin with common symptoms such as "I have indigestion," "my upper right abdomen feels bloated," or "my stomach feels uncomfortable after meals." Because these symptoms are also common in gastritis, gallstones, functional dyspepsia, and similar conditions, it is difficult to distinguish gallbladder cancer by symptoms alone. A symptom mentioned relatively often is pain or discomfort in the upper right abdomen. The pain may feel dull and like a sense of pressure rather than sharp, and it may appear intermittently.

As the disease progresses, systemic symptoms may appear. Appetite decreases and weight is lost, and a person may tire easily and feel general weakness. A low-grade fever of unknown cause may also persist. Symptoms such as nausea, vomiting, and bloating after meals may accompany these.

Jaundice is one of the important warning signs. When the tumor blocks or compresses the bile duct (the passage through which bile flows), the skin and whites of the eyes may turn yellow, the urine may become dark, and the stool may become pale. Itching may also become severe due to bile stagnation. However, it is good to remember that jaundice is usually more common in advanced situations.

Signs

Signs are objective findings confirmed by examination or testing. The representative signs in gallbladder cancer are findings related to jaundice. The whites of the eyes (sclera) may turn yellow or the skin may appear yellow, and changes such as dark urine and pale stools may accompany this. There may be tenderness when the upper right abdomen is pressed, or in advanced cases a mass (lump) may be felt. The liver may be enlarged (hepatomegaly), or findings suggesting liver infiltration or metastasis may be seen on imaging.

If there are fever and chills, it may be a situation in which cholangitis has developed due to bile duct obstruction, and emergency evaluation may be needed. Ascites (a condition in which fluid accumulates in the abdomen) or abdominal distension are signs that can appear in advanced disease, such as peritoneal metastasis. In the early stage of gallbladder cancer, these signs may not be evident, so if there are risk factors or abnormal findings are seen on imaging, evaluation is needed even if the symptoms are mild.

Screening

For gallbladder cancer, no standard screening program targeting the entire population has been established. This is because its incidence is relatively low and the benefit gained from performing regular detailed tests on everyone may be limited. However, follow-up observation can be helpful in people at high risk. For example, if gallstones have been present for a long time, a gallbladder polyp has been found, calcification of the gallbladder wall is suspected, or there is a structural abnormality of the bile ducts, the doctor may suggest a follow-up testing plan. The test most commonly used in such cases is abdominal ultrasound (US).

Regularly measuring only tumor markers through blood tests has major limitations as a screening test for gallbladder cancer. This is because they can rise even in inflammation or bile duct obstruction that is not cancer, and they may be normal in early cancer. In summary, for gallbladder cancer screening, an approach of "ultrasound-centered observation according to individual risk" is more realistic than one "targeting the entire population," and the follow-up interval varies depending on changes in polyp size or the condition of the gallbladder.

Diagnosis

The diagnosis of gallbladder cancer proceeds by combining the medical history and examination, blood tests, and imaging tests step by step. The doctor checks the pattern of pain, changes in weight, presence of jaundice, fever, history of gallstones and cholecystitis, presence of gallbladder polyps, and so on. Blood tests, including liver function tests (LFT), look for a pattern of bile stagnation. Total/direct bilirubin, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and similar values serve as references. Tumor markers (CA 19-9, CEA) can be consulted as supplementary information, but they alone do not provide grounds for a definitive diagnosis.

Imaging tests are central. Abdominal ultrasound (US), as the first evaluation, checks for a gallbladder mass, gallbladder wall thickening, bile duct dilation, and accompanying gallstones. Contrast-enhanced CT is important for staging and evaluates liver infiltration and metastasis, lymph nodes, and vascular invasion. MRI and MRCP are useful for evaluating the structure of the bile ducts, the level of obstruction, and soft tissue invasion. Depending on the situation, PET-CT can also help in evaluating distant metastasis.

Tissue examination is chosen depending on the situation. If surgery is judged to be possible, the diagnosis is often confirmed by postoperative pathological examination, and when resection appears difficult or nonsurgical treatment is planned, confirmation may be attempted by endoscopic ultrasound (EUS)-guided biopsy or image-guided biopsy. The diagnosis is completed by synthesizing imaging findings + blood tests + histopathology.

Treatment

Treatment of gallbladder cancer varies depending on the stage and the patient's general condition. The most important treatment that can aim for a cure is surgery. At a very early stage (confined to the gallbladder), cholecystectomy alone may be sufficient, but in many cases an extended operation is needed that includes resection of part of the liver tissue around the gallbladder and lymph node dissection. The extent of surgery is determined by the depth of the tumor, whether it has invaded surrounding structures, and the condition of the lymph nodes. After surgery, adjuvant therapy to lower the risk of recurrence may be considered. Chemotherapy may be given for a certain period, and in certain situations radiation therapy may also be discussed.

In advanced or metastatic gallbladder cancer, surgery is often difficult, so chemotherapy becomes central. The goal is to shrink the tumor, relieve symptoms, and extend survival. Recently, in some patients, targeted therapy or immunotherapy may be chosen according to the characteristics of the tumor (genetic changes, immune-related markers, etc.).

When jaundice is severe, a procedure such as stent placement may be needed for bile drainage, and palliative care, such as management of pain, nutrition, and infection, is also an important part of treatment. At any stage, the treatment direction is decided individually by comprehensively considering the stage, general condition, and the patient's wishes.

Prognosis

The prognosis of gallbladder cancer depends greatly on the stage at the time of discovery. If it is found at a very early stage in which the tumor is confined to the gallbladder mucosa, a cure can be expected with surgery. Conversely, because the gallbladder is very close to the liver and is in an environment where cancer can spread through lymphatic vessels and blood vessels, treatment can become difficult if it is found in an advanced state. Factors affecting prognosis include the depth of tumor invasion, whether the liver or surrounding organs are invaded, whether there is lymph node metastasis, whether there is distant metastasis, and whether the tumor was removed cleanly by surgery (resection margin status).

In actual practice, there are cases in which cancer is incidentally discovered after a cholecystectomy for gallstones; such cases may be relatively early, so the prognosis may be on the better side. Conversely, if it was first discovered because of jaundice, weight loss, ascites, or similar findings, it is likely to be advanced. Even at the same stage, the course can differ depending on nutritional status, liver function, comorbidities, and the physical strength to tolerate treatment.

Prevention

There is no certain way to prevent gallbladder cancer 100%, but there are strategies that help lower the risk. The key is to reduce situations in which chronic irritation and inflammation persist in the gallbladder for a long time. If there are gallstones and symptoms recur or the risk of complications is high, long-term inflammatory irritation can be reduced through cholecystectomy when medically necessary. However, not everyone with gallstones is a candidate for surgery, so the decision is made by considering symptoms and risks together. For gallbladder polyps, follow-up observation or surgery is considered according to their size, shape, and rate of growth.

In terms of lifestyle, preventing obesity, eating a balanced diet, and exercising regularly may help lower overall risk. Because smoking increases the risk of many cancers, quitting smoking is recommended. If one has diabetes, managing blood sugar well and maintaining metabolic health may be beneficial in the long term.

When a gallbladder abnormality is found on ultrasound during a health checkup or for another reason, rather than leaving it alone because there are no symptoms, receiving the follow-up ultrasound or additional imaging tests recommended by the doctor at appropriate intervals is the most realistic prevention strategy for "early detection and risk reduction." It is also important to consult a specialist and establish a management plan for special situations such as structural abnormalities of the bile ducts or gallbladder calcification.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.